A recent study [22] showed that patients diagnosed by PSA who underwent radical prostatectomy did not have a significant reduction in all-cause or PCa mortality as compared with those diagnosed by PSA, but who opted for active surveillance over a 12-year follow-up. The gene discussed is KLK3; the disease is posterior cortical atrophy.